Smart for Life to Attend IFT FIRST Annual Event and Expo in Chicago
Company Aims to Forge Strategic Partnerships and Explore Acquisition Opportunities at Leading Food Science Event
MIAMI, July 02, 2024 (GLOBE NEWSWIRE) — Smart for Life, Inc. (Nasdaq: SMFL) (“Smart for Life” or the “Company”), a distinguished leader in the Health & Wellness sector specializing in the marketing and manufacturing of nutritional supplements and foods, today announced its upcoming participation at the Institute of Food Technologists (IFT) FIRST Annual Event and Expo, taking place from July 14-17, 2024, in Chicago, Illinois.
The IFT FIRST Annual Event is a premier gathering of the brightest minds in food science, technology, and related fields. It offers a dynamic platform for professionals to exchange ideas, discover new research, and forge valuable connections. Smart for Life will be actively seeking meetings to discuss potential acquisitions and strategic partnerships that align with the latest advancements in food science.
“The upcoming IFT event represents a strategic effort to broaden our reach and strengthen our position in the functional foods market,” stated Darren Minton, CEO of Smart for Life. “This is a great opportunity to engage with industry leaders, explore potential partnerships, and identify acquisition opportunities that align with our growth strategy. Smart for Life continues to support the latest advancements in food science initiatives.”
The Institute of Food Technologists (IFT) is a global organization dedicated to advancing the science of food. Through its annual event and numerous initiatives, IFT brings together food professionals from around the world to share knowledge, foster innovation, and address the challenges facing the food industry.
Smart for Life will have dedicated representatives at the conference to meet with companies interested in collaboration and business development. Attendees interested in scheduling a meeting with Smart for Life during the IFT FIRST event are encouraged to contact the company directly to arrange appointments. Meetings will focus on exploring avenues for collaboration that can drive mutual growth and innovation, encompassing a wide range of opportunities from acquisitions to strategic partnerships.
For media inquiries or to schedule interviews with Smart for Life representatives, please contact: media@smartforlifecorp.com.
About IFT FIRST
IFT FIRST means Food Improved by Research, Science, and Technology. It is IFT’s response to the transformative nature of the global food system. IFT FIRST will bring together researchers, scientists, engineers and entrepreneurs from across the global food value chain to discuss scientific solutions in presentations and panels focused on transformative innovation. For more information about the IFT FIRST Annual Event and Expo, please visit: www.iftevent.org.
About Smart for Life, Inc.
Smart for Life, Inc. (Nasdaq: SMFL) is an emerging growth company in the nutraceutical industry, committed to delivering innovative solutions that promote Health & Wellness. With a focus on research-driven formulations and consumer-centric approaches, Smart for Life is dedicated to redefining the boundaries of nutritional science. The Company is engaged in the development, marketing, manufacturing, acquisition, operation and sale of a broad spectrum of nutritional and products. Structured as a publicly held holding company, the Company is executing a Buy-and-Build strategy with serial accretive acquisitions creating a vertically integrated company. To drive growth and earnings, Smart for Life is developing proprietary and related products as well as acquiring other profitable companies, encompassing brands, manufacturing and distribution channels. The Company recently concluded the execution of a restructuring plan including recapitalization of the Company with equity and debt financings, the sale of certain non-performing assets, the sale and leaseback of the Company’s 18,000 sq. ft. Doral manufacturing facility and the successful liquidation of the Company’s senior debt facility. In addition, the Company converted substantial debt obligations to equity, materially improving the Company’s balance sheet. The Company has signed a definitive agreement for the acquisition of Purely Optimal Nutrition, which is expected to add additional revenue and EBITDA. For more information about Smart for Life, please visit: www.smartforlifecorp.com.
Forward-Looking Statements
This press release may contain information about our views of future expectations, plans and prospects that constitute forward-looking statements. All forward-looking statements are based on management’s beliefs, assumptions and expectations of Smart for Life’s future economic performance, taking into account the information currently available to it. These statements are not statements of historical fact. Although Smart for Life believes the expectations reflected in such forward-looking statements are based on reasonable assumptions, it can give no assurance that its expectations will be attained. Smart for Life does not undertake any duty to update any statements contained herein (including any forward-looking statements), except as required by law. No assurances can be made that Smart for Life will successfully acquire its acquisition targets. Forward-looking statements are subject to a number of factors, risks and uncertainties, some of which are not currently known to us, that may cause Smart for Life’s actual results, performance or financial condition to be materially different from the expectations of future results, performance or financial position. Actual results may differ materially from the expectations discussed in forward-looking statements. Factors that could cause actual results to differ materially from expectations include general industry considerations, regulatory changes, changes in local or national economic conditions and other risks set forth in “Risk Factors” included in our filings with the Securities and Exchange Commission.
Disclaimer
The information provided in this press release is intended for general knowledge only and is not a substitute for professional medical advice or treatment for specific medical conditions. Always seek the advice of your physician or other qualified health care provider with any questions you may have regarding a medical condition. This information is not intended to diagnose, treat, cure or prevent any disease.
Investor Relations Contact
Crescendo Communications, LLC
Tel: (212) 671-1021
SMFL@crescendo-ir.com
